Your browser doesn't support javascript.
loading
How to: Establish and run a stool bank.
Terveer, E M; van Beurden, Y H; Goorhuis, A; Seegers, J F M L; Bauer, M P; van Nood, E; Dijkgraaf, M G W; Mulder, C J J; Vandenbroucke-Grauls, C M J E; Verspaget, H W; Keller, J J; Kuijper, E J.
Affiliation
  • Terveer EM; Dept. of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: e.m.terveer@lumc.nl.
  • van Beurden YH; Dept. of Medical Microbiology & Infection Control, VU University Medical Center, Amsterdam, The Netherlands; Dept. of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands.
  • Goorhuis A; Dept. of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.
  • Seegers JFML; Dept. of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.
  • Bauer MP; Dept. of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • van Nood E; Dept. of Internal Medicine, Havenziekenhuis, Rotterdam, The Netherlands.
  • Dijkgraaf MGW; Clinical Research Unit, Academic Medical Center, Amsterdam, The Netherlands.
  • Mulder CJJ; Dept. of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands.
  • Vandenbroucke-Grauls CMJE; Dept. of Medical Microbiology & Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
  • Verspaget HW; Dept. of Biobanking and Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands.
  • Keller JJ; Dept. of Gastroenterology, MC Haaglanden, The Hague, The Netherlands; Dept. of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: j.keller@haaglandenmc.nl.
  • Kuijper EJ; Dept. of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Clin Microbiol Infect ; 23(12): 924-930, 2017 Dec.
Article in En | MEDLINE | ID: mdl-28529025
ABSTRACT

BACKGROUND:

Since 2013, several stool banks have been developed following publications reporting on clinical success of 'faecal microbiota transplantation' (FMT) for recurrent Clostridium difficile infections (CDI). However, protocols for donor screening, faecal suspension preparation, and transfer of the faecal suspension differ between countries and institutions. Moreover, no European consensus exists regarding the legislative aspects of the faecal suspension product. Internationally standardized recommendations about the above mentioned aspects have not yet been established.

OBJECTIVE:

In 2015, the Netherlands Donor Feces Bank (NDFB) was founded with the primary aim of providing a standardized product for the treatment of patients with recurrent CDI in the Netherlands. Standard operation procedures for donor recruitment, donor selection, donor screening, and production, storage, and distribution of frozen faecal suspensions for FMT were formulated. RESULTS AND

DISCUSSION:

Our experience summarized in this review addresses current donor recruitment and screening, preparation of the faecal suspension, transfer of the faecal microbiota suspension, and the experiences and follow-up of the patients treated with donor faeces from the NDFB.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Specimen Banks / Feces / Fecal Microbiota Transplantation Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Specimen Banks / Feces / Fecal Microbiota Transplantation Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2017 Document type: Article